Goldman Sachs’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $146M | Buy |
666,328
+62,595
| +10% | +$13.7M | 0.02% | 593 |
|
2025
Q1 | $135M | Buy |
603,733
+91,707
| +18% | +$20.5M | 0.02% | 573 |
|
2024
Q4 | $168M | Buy |
512,026
+96,408
| +23% | +$31.6M | 0.03% | 479 |
|
2024
Q3 | $125M | Sell |
415,618
-57,995
| -12% | -$17.4M | 0.02% | 602 |
|
2024
Q2 | $156M | Buy |
473,613
+11,305
| +2% | +$3.72M | 0.03% | 520 |
|
2024
Q1 | $183M | Buy |
462,308
+28,119
| +6% | +$11.1M | 0.03% | 461 |
|
2023
Q4 | $153M | Sell |
434,189
-40,107
| -8% | -$14.1M | 0.03% | 508 |
|
2023
Q3 | $178M | Sell |
474,296
-50,912
| -10% | -$19.1M | 0.04% | 414 |
|
2023
Q2 | $201M | Buy |
525,208
+21,171
| +4% | +$8.1M | 0.04% | 373 |
|
2023
Q1 | $175M | Buy |
504,037
+70,587
| +16% | +$24.5M | 0.04% | 410 |
|
2022
Q4 | $102M | Buy |
433,450
+49,602
| +13% | +$11.7M | 0.03% | 606 |
|
2022
Q3 | $94.5M | Sell |
383,848
-40,101
| -9% | -$9.87M | 0.02% | 628 |
|
2022
Q2 | $128M | Sell |
423,949
-134,796
| -24% | -$40.8M | 0.03% | 503 |
|
2022
Q1 | $229M | Buy |
558,745
+53,044
| +10% | +$21.8M | 0.05% | 339 |
|
2021
Q4 | $237M | Buy |
505,701
+13,909
| +3% | +$6.52M | 0.05% | 341 |
|
2021
Q3 | $209M | Sell |
491,792
-321,172
| -40% | -$136M | 0.04% | 360 |
|
2021
Q2 | $292M | Sell |
812,964
-324,378
| -29% | -$116M | 0.07% | 245 |
|
2021
Q1 | $320M | Sell |
1,137,342
-113,530
| -9% | -$32M | 0.08% | 196 |
|
2020
Q4 | $354M | Sell |
1,250,872
-84,904
| -6% | -$24.1M | 0.09% | 172 |
|
2020
Q3 | $367M | Buy |
1,335,776
+432,092
| +48% | +$119M | 0.1% | 140 |
|
2020
Q2 | $205M | Buy |
903,684
+41,013
| +5% | +$9.32M | 0.06% | 273 |
|
2020
Q1 | $131M | Sell |
862,671
-43,185
| -5% | -$6.57M | 0.05% | 374 |
|
2019
Q4 | $136M | Sell |
905,856
-86,939
| -9% | -$13.1M | 0.03% | 500 |
|
2019
Q3 | $141M | Buy |
992,795
+63,410
| +7% | +$8.99M | 0.04% | 445 |
|
2019
Q2 | $116M | Sell |
929,385
-148,773
| -14% | -$18.6M | 0.03% | 541 |
|
2019
Q1 | $119M | Buy |
1,078,158
+155,115
| +17% | +$17.1M | 0.04% | 523 |
|
2018
Q4 | $90.5M | Sell |
923,043
-50,073
| -5% | -$4.91M | 0.03% | 605 |
|
2018
Q3 | $120M | Buy |
973,116
+162,252
| +20% | +$20M | 0.03% | 591 |
|
2018
Q2 | $80.5M | Buy |
810,864
+143,818
| +22% | +$14.3M | 0.02% | 813 |
|
2018
Q1 | $58.9M | Sell |
667,046
-110,223
| -14% | -$9.73M | 0.02% | 973 |
|
2017
Q4 | $76.7M | Sell |
777,269
-204,354
| -21% | -$20.2M | 0.02% | 839 |
|
2017
Q3 | $94.5M | Buy |
981,623
+45,938
| +5% | +$4.42M | 0.02% | 722 |
|
2017
Q2 | $88.4M | Buy |
935,685
+86,022
| +10% | +$8.13M | 0.02% | 727 |
|
2017
Q1 | $69.3M | Sell |
849,663
-76,145
| -8% | -$6.21M | 0.02% | 844 |
|
2016
Q4 | $78.5M | Buy |
925,808
+15
| +0% | +$1.27K | 0.02% | 746 |
|
2016
Q3 | $69M | Buy |
925,793
+242,215
| +35% | +$18M | 0.02% | 801 |
|
2016
Q2 | $51.9M | Buy |
683,578
+57,564
| +9% | +$4.37M | 0.02% | 891 |
|
2016
Q1 | $43.4M | Buy |
626,014
+342,331
| +121% | +$23.7M | 0.01% | 981 |
|
2015
Q4 | $17.1M | Buy |
283,683
+85,604
| +43% | +$5.15M | 0.01% | 1414 |
|
2015
Q3 | $10.7M | Buy |
198,079
+68,879
| +53% | +$3.73M | ﹤0.01% | 1609 |
|
2015
Q2 | $7.5M | Sell |
129,200
-8,532
| -6% | -$496K | ﹤0.01% | 1840 |
|
2015
Q1 | $8.29M | Buy |
137,732
+101,561
| +281% | +$6.11M | ﹤0.01% | 1768 |
|
2014
Q4 | $1.93M | Sell |
36,171
-13,763
| -28% | -$733K | ﹤0.01% | 2530 |
|
2014
Q3 | $2.24M | Sell |
49,934
-9,993
| -17% | -$447K | ﹤0.01% | 2454 |
|
2014
Q2 | $2.53M | Buy |
59,927
+11,657
| +24% | +$492K | ﹤0.01% | 2404 |
|
2014
Q1 | $2.13M | Sell |
48,270
-135,573
| -74% | -$5.97M | ﹤0.01% | 2516 |
|
2013
Q4 | $9.02M | Buy |
183,843
+40,966
| +29% | +$2.01M | ﹤0.01% | 1620 |
|
2013
Q3 | $5.88M | Buy |
142,877
+34,421
| +32% | +$1.42M | ﹤0.01% | 1794 |
|
2013
Q2 | $3.81M | Buy |
+108,456
| New | +$3.81M | ﹤0.01% | 1931 |
|